18,955
Participants
Start Date
March 31, 2012
Primary Completion Date
November 30, 2013
Study Completion Date
May 31, 2014
Leiden University Medical Center, Leiden
Maastricht University Medical Center, Maastricht
Columbia University, New York
Karolinska University Hospital, Stockholm
Abington Memorial Hospital, Abington
Women's Health Care Group of Pennsylvania, Wynnewood
Thomas Jefferson Univeristy Hospital, Philadelphia
Christiana Care Health System, Newark
Duke University Medical Center, Durham
Altus Research, Lake Worth
Norton Healthcare, Louisville
Medical College of Wisconsin, Milwaukee
Minnesota Perinatal Associates, Minneapolis
Northshore University Health System, Evanston
Tucson Medical Center, Tucson
The Institute of Prenatal Diagnosis and Reproductive Medicine, San Gabriel
Perinatal Diagnostic Center, Riverside
California Pacific Medical Center, San Francisco
University of California San Francisco, San Francisco
East Bay Perinatal Associates, Oakland
Fetal Diagnostic Institute of the Pacific, Honolulu
Northwest Perinatal Center, Portland
Oregon Health Sciences University, Portland
Stanford University, Palo Alto
University of California San Diego, San Diego
Brigham and Women's Hospital - Center for Fetal Medicine and Prenatal Genetics, Boston
Robert Wood Johnson School of Medicine, New Brunswick
St. Peters University Medical Center, New Brunswick
Partners in Obstetrics and Gynecology, Pawtucket
University Hospitals Leuven, Leuven
Early Risk Assessment Program - University of Alberta, Calgary
Ottawa Hospital and Research Institute, Ottawa
Mount Sinai University, Toronto
University of Toronto, Toronto
University of Perugia, Perugia
Sahlgrenska University Medical Center, Gothenburg
Perinatal Quality Foundation: Nuchal Translucency Quality Review
UNKNOWN
Roche Sequencing Solutions
INDUSTRY